PROCR and facioscapulohumeral muscular dystrophy: Given the results obtained in our in vitro model, we also evaluated non-myogenic mesenchymal cell localisation and distribution in a larger cohort of control and FSHD skeletal muscle sections using CD201 and PDGFRA as markers [29, 32].